Stemline Therapeutics Inc (NASDAQ:STML)

15.90
Delayed Data
As of Feb 16
 -0.05 / -0.31%
Today’s Change
6.35
Today|||52-Week Range
17.40
+1.92%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hoberman Kenneth
Chief Operating Officer
Sale1/08/201814,040$13.93$195.6K+14.39%
Hoberman Kenneth
Chief Operating Officer
Sale12/15/201711,943$14.18$169.4K+7.80%
Bergstein Ivan
Chief Executive Officer
Sale2/28/201710,480$7.01$73.5K+127.14%
Gionco David G
Chief Accounting Officer
Sale1/17/20184,250$13.43$57.1K+18.22%
Bergstein Ivan
Chief Executive Officer
Sale2/27/20177,500$6.97$52.3K+125.53%
Bergstein Ivan
Chief Executive Officer
Sale3/07/20175,401$8.13$43.9K+98.75%
Hoberman Kenneth
Chief Operating Officer
Sale2/28/20174,027$7.01$28.2K+127.14%
Hoberman Kenneth
Chief Operating Officer
Sale2/27/20174,000$6.97$27.9K+125.53%
Gionco David G
Chief Accounting Officer
Sale2/27/20173,500$6.97$24.4K+125.53%
Gionco David G
Chief Accounting Officer
Sale2/28/20172,986$7.01$20.9K+127.14%
Page of 2